Register for free to
view the full innovation profile.
Cell3TMDirect qPCR amplification technology enables direct from plasma, non-invasive, accurate and reproducible prenatal testing.
About
Description: Cell3TMDirect qPCR amplification technology enables direct from plasma, non-invasive, accurate and reproducible prenatal testing. The Cell3TMDirect kit contains pre-plated primers and probes in a flexible break-apart 96 well format and includes all components for direct from plasma or extracted cfDNA amplification using any common qPCR / Real-Time PCR System. Positive and negative controls are included in the kit for your convenience. Benefits: Direct from Maternal Plasma – No cfDNA extraction required. Simple Real-Time qPCR protocol delivers accurate results direct from plasma. Reduced Costs – Direct from plasma approach saves technician time and extraction costs associated with current home brew methods. Flexible and Validated Kit – 96 well formatting within a break-apart plate allows for between 4 and 13 samples per kit while the validated protocol ensures robust and accurate reporting of findings.